2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 16:35, 21 November 2023
, 21 November 2023→Clinical Trials
| Line 321: | Line 321: | ||
|- | |- | ||
|{{pmid text|34912838}} | |{{pmid text|34912838}} | ||
| | |||
| | |||
| | |||
|- | |||
|{{pmid text|36797393}} | |||
| | | | ||
| | | | ||